Literature DB >> 18719003

In vitro optimization of dexamethasone phosphate delivery by iontophoresis.

Jean-Philippe Sylvestre1, Richard H Guy, M Begoña Delgado-Charro.   

Abstract

BACKGROUND AND
PURPOSE: This study was designed to evaluate the effects of competing ions and electroosmosis on the transdermal iontophoresis of dexamethasone phosphate (Dex-Phos) and to identify the optimal conditions for its delivery.
METHODS: The experiments were performed using pig skin, in side-by-side diffusion cells (0.78 cm(2)), passing a constant current of 0.3 mA via Ag-AgCl electrodes. Dex-Phos transport was quantified for donor solutions (anodal and cathodal) containing different drug concentrations, with and without background electrolyte. Electrotransport of co-ion, citrate, and counterions Na(+) and K(+) also was quantified. The contribution of electroosmosis was evaluated by measuring the transport of the neutral marker (mannitol).
RESULTS: Electromigration was the dominant mechanism of drug iontophoresis, and reduction in electroosmotic flow directed against the cathodic delivery of Dex-Phos did not improve drug delivery. The Dex-Phos flux from the cathode was found to be optimal (transport number of approximately 0.012) when background electrolyte was excluded from the formulation. In this case, transport of the drug is limited principally by the competition with counterions (mainly Na(+) with a transport number of approximately 0.8) and the mobility of the drug in the membrane. DISCUSSION AND
CONCLUSION: Dex-Phos must be delivered from the cathode and formulated rationally, excluding mobile co-anions, to achieve optimal iontophoretic delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719003      PMCID: PMC2557054          DOI: 10.2522/ptj.20080043

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  28 in total

Review 1.  What can family physicians offer patients with carpal tunnel syndrome other than surgery? A systematic review of nonsurgical management.

Authors:  Felicity Goodyear-Smith; Bruce Arroll
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

Review 2.  Iontophoretic drug delivery.

Authors:  Yogeshvar N Kalia; Aarti Naik; James Garrison; Richard H Guy
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

Review 3.  Injectable corticosteroids in treatment of arthritis of the knee.

Authors:  H Ralph Schumacher; Lan X Chen
Journal:  Am J Med       Date:  2005-11       Impact factor: 4.965

Review 4.  Injectable corticosteroids in modern practice.

Authors:  Brian J Cole; H Ralph Schumacher
Journal:  J Am Acad Orthop Surg       Date:  2005 Jan-Feb       Impact factor: 3.020

5.  Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

6.  The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis.

Authors:  J M Glass; R L Stephen; S C Jacobson
Journal:  Int J Dermatol       Date:  1980-11       Impact factor: 2.736

7.  Contributions of electromigration and electroosmosis to iontophoretic drug delivery.

Authors:  D Marro; Y N Kalia; M B Delgado-Charro; R H Guy
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

8.  Physician prescribing patterns of oral corticosteroids for musculoskeletal injuries.

Authors:  Kimberly G Harmon; Chris Hawley
Journal:  J Am Board Fam Pract       Date:  2003 May-Jun

9.  Quantitative structure-permeation relationship for iontophoretic transport across the skin.

Authors:  Blaise Mudry; Pierre-Alain Carrupt; Richard H Guy; M Begoña Delgado-Charro
Journal:  J Control Release       Date:  2007-07-19       Impact factor: 9.776

10.  Electromigration of ions across the skin: determination and prediction of transport numbers.

Authors:  Blaise Mudry; Richard H Guy; M Begoña Delgado-Charro
Journal:  J Pharm Sci       Date:  2006-03       Impact factor: 3.534

View more
  6 in total

1.  Iontophoresis-facilitated delivery of prednisolone through throat skin to the trachea after topical application of its succinate salt.

Authors:  Hiroshi Ishii; Tsukasa Suzuki; Hiroaki Todo; Mitsuhiro Kamimura; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

2.  Iontophoresis of dexamethasone phosphate: competition with chloride ions.

Authors:  J-P Sylvestre; C Díaz-Marín; M B Delgado-Charro; R H Guy
Journal:  J Control Release       Date:  2008-07-06       Impact factor: 9.776

3.  Modeling iontophoretic drug delivery in a microfluidic device.

Authors:  Maryam Moarefian; Rafael V Davalos; Danesh K Tafti; Luke E Achenie; Caroline N Jones
Journal:  Lab Chip       Date:  2020-09-01       Impact factor: 6.799

4.  Iontophoretic transdermal sampling of iohexol as a non-invasive tool to assess glomerular filtration rate.

Authors:  Asma Djabri; William van't Hoff; Penelope Brock; Ian C K Wong; Richard H Guy; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2014-09-05       Impact factor: 4.200

5.  Iontophoresis Improved Growth Reduction of Invasive Squamous Cell Carcinoma in Topical Photodynamic Therapy.

Authors:  Camila Nunes Lemos; Joel Gonçalves de Souza; Patrícia Sper Simão; Renata Fonseca Vianna Lopez
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

6.  Suppression of Fibrotic Reactions of Chitosan-Alginate Microcapsules Containing Porcine Islets by Dexamethasone Surface Coating.

Authors:  Min Jung Kim; Heon-Seok Park; Ji-Won Kim; Eun-Young Lee; Marie Rhee; Young-Hye You; Gilson Khang; Chung-Gyu Park; Kun-Ho Yoon
Journal:  Endocrinol Metab (Seoul)       Date:  2021-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.